FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175442607> ?p ?o ?g. }

• W3175442607 abstract "Chemotherapy utilizing cytotoxic drugs such as paclitaxel (PTX) is still a major therapeutic approach to treat both localized and metastasized cancers. Unlike traditional regimens, where PTX is administered at the maximum tolerated dose, alternative regimen like metronomic dosing are proving beneficial, where PTX is administered more frequently and in much lower doses exploring anti-angiogenic and immunomodulatory effects. However, PTX-induced peripheral neuropathy (PIPN) and lack of non-invasive dosage forms of PTX are major roadblocks for the successful implementation of metronomic regimens. Given the success of polyester nanoparticle drug delivery, our aim was to explore the potential of nanoparticle-encapsulated paclitaxel (nPTX) in alleviating PIPN in an experimental rat model. In this study, rats were injected intraperitoneal with 2 mg/kg body weight of PTX or nPTX on four alternate days and PIPN was characterized using behavioral assessments, histology and immunohistochemistry. PIPN was revealed by a significant decrease in the tactile sensitivity and pressure pain threshold in PTX group compared to the nPTX group over a 16-day study period. The behavior data was supported by histological assessments, where PTX group showed a higher degree of dorsal root ganglion (DRG) degeneration and a significant reduction in motor neurons compared to nPTX group. Further, immunofluorescence data reveals increase in the density of neuronal marker β-tubulin-III (TUBB3), reduced TUNEL positive cells and increase in high molecular weight neurofilament (NFH) in spinal cord, DRG and sciatic nerve for nPTX group. Therefore, this work has important implications in improving risk-benefit profile of PTX, paving way for metronomic regimens. The characteristics of nPTX used in this present study. a) Table showing the formulation characteristics of different batches b) Representative dynamic light scattering particle size distribution profile and c) Representative scanning electron micrograph of nPTX. *The difference in the entrapment numbers is not the reproducibility issue, but different volume of the suspension used in the vial for freeze drying. nPTX reduces the pain hypersensitivity of rats compared to those treated with PTX. a) Tactile threshold and b) Pressure threshold, time course of the effect of intraperitoneal injections of PTX and nPTX at 2mg/kg administered as indicated by arrows on x-axis. BL is baseline data. We used same rats in a & b experiments. *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 comparisons were made between PTX vs nPTX; two-way analysis of variance followed by Tukey's multiple comparisons test (n=8). nPTX prevents dorsal root ganglion (DRG) degeneration. a) H&E-stained sections were prepared from the DRG nerve at the end of the study. b) PTX group showed degeneration of neurons presenting significantly low in DRG numbers compared to nPTX group indicated with bright red arrowheads. c) PTX levels in DRG, PTX and nPTX groups are not significant. ***p < 0.001 comparisons were made between PTX vs nPTX; two-way analysis of variance followed by Tukey's multiple comparisons test. nPTX increase motor neuron survival in spinal cord (SC) region. a) Representative images of ventral root horn spinal cords of PTX and nPTX treated rats. b) SC motor neuron counts significantly decreased in PTX groups compared to nPTX. Images were acquired at 10 and 40x original magnification. c) PTX levels in SC, PTX and nPTX groups are not significant. The PTX levels between DRG and SC are about 100 orders of magnitude, presumably due to the deficiency in blood-nerve barrier in the former. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal." @default.
• W3175442607 created "2021-07-05" @default.
• W3175442607 creator A5025851353 @default.
• W3175442607 creator A5034299848 @default.
• W3175442607 creator A5043662614 @default.
• W3175442607 creator A5074919402 @default.
• W3175442607 creator A5082040765 @default.
• W3175442607 date "2019-04-01" @default.
• W3175442607 modified "2023-09-27" @default.
• W3175442607 title "Polyester nanoparticle‐encapsulated paclitaxel mitigates paclitaxel‐induced peripheral neuropathy" @default.
• W3175442607 doi "https://doi.org/10.1096/fasebj.2019.33.1_supplement.813.8" @default.
• W3175442607 hasPublicationYear "2019" @default.
• W3175442607 type Work @default.
• W3175442607 sameAs 3175442607 @default.
• W3175442607 citedByCount "0" @default.
• W3175442607 crossrefType "journal-article" @default.
• W3175442607 hasAuthorship W3175442607A5025851353 @default.
• W3175442607 hasAuthorship W3175442607A5034299848 @default.
• W3175442607 hasAuthorship W3175442607A5043662614 @default.
• W3175442607 hasAuthorship W3175442607A5074919402 @default.
• W3175442607 hasAuthorship W3175442607A5082040765 @default.
• W3175442607 hasConcept C118552586 @default.
• W3175442607 hasConcept C126322002 @default.
• W3175442607 hasConcept C134018914 @default.
• W3175442607 hasConcept C2776281502 @default.
• W3175442607 hasConcept C2776694085 @default.
• W3175442607 hasConcept C2777107010 @default.
• W3175442607 hasConcept C2777292972 @default.
• W3175442607 hasConcept C2779901536 @default.
• W3175442607 hasConcept C2780775167 @default.
• W3175442607 hasConcept C42219234 @default.
• W3175442607 hasConcept C555293320 @default.
• W3175442607 hasConcept C71924100 @default.
• W3175442607 hasConcept C98274493 @default.
• W3175442607 hasConceptScore W3175442607C118552586 @default.
• W3175442607 hasConceptScore W3175442607C126322002 @default.
• W3175442607 hasConceptScore W3175442607C134018914 @default.
• W3175442607 hasConceptScore W3175442607C2776281502 @default.
• W3175442607 hasConceptScore W3175442607C2776694085 @default.
• W3175442607 hasConceptScore W3175442607C2777107010 @default.
• W3175442607 hasConceptScore W3175442607C2777292972 @default.
• W3175442607 hasConceptScore W3175442607C2779901536 @default.
• W3175442607 hasConceptScore W3175442607C2780775167 @default.
• W3175442607 hasConceptScore W3175442607C42219234 @default.
• W3175442607 hasConceptScore W3175442607C555293320 @default.
• W3175442607 hasConceptScore W3175442607C71924100 @default.
• W3175442607 hasConceptScore W3175442607C98274493 @default.
• W3175442607 hasIssue "S1" @default.
• W3175442607 hasLocation W31754426071 @default.
• W3175442607 hasOpenAccess W3175442607 @default.
• W3175442607 hasPrimaryLocation W31754426071 @default.
• W3175442607 hasRelatedWork W2093674756 @default.
• W3175442607 hasRelatedWork W2416509320 @default.
• W3175442607 hasRelatedWork W2567561165 @default.
• W3175442607 hasRelatedWork W2908257413 @default.
• W3175442607 hasRelatedWork W2963086616 @default.
• W3175442607 hasRelatedWork W2989575247 @default.
• W3175442607 hasRelatedWork W3194197894 @default.
• W3175442607 hasRelatedWork W4210473878 @default.
• W3175442607 hasRelatedWork W4308372091 @default.
• W3175442607 hasRelatedWork W4313584630 @default.
• W3175442607 hasVolume "33" @default.
• W3175442607 isParatext "false" @default.
• W3175442607 isRetracted "false" @default.
• W3175442607 magId "3175442607" @default.
• W3175442607 workType "article" @default.